Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
Titel:
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
Auteur:
Younes, Anas Oki, Yasuhiro McLaughlin, Peter Copeland, Amanda R. Goy, Andre Pro, Barbara Feng, Lei Yuan, Ying Chuang, Hubert H. Macapinlac, Homer A. Hagemeister, Fredrick Romaguera, Jorge Samaniego, Felipe Fanale, Michelle A. Dabaja, Bouthaina Shbib Rodriguez, Maria A. Dang, Nam Kwak, Larry W. Neelapu, Sattva S. Fayad, Luis E.